Same, idean.I think this is a terrific...

Same, idean.

I think this is a terrific announcement/development.

I also think the market is waiting to see which they go with InHealth.

In the Half Yearly they said:

"On or before the conversion date - 1 July 2020 - your Board will make a decision as to what is in the best interests of CardieX as far as our ongoing ownership and equity participation."

In the most recent quarterly update they said:

"We will shortly be making a determination as to whether we increase our ownership of inHealth pursuant to our rights under the Convertible Note and Option Agreement."

While talking up the global trend and importance of Telehealth - "our consumer health investment in inHealth continues with positive momentum for the company in terms of new market development and revenues" - the language re their intentions seems somewhat ambiguous.

Will they proceed with the CN and the Option?

In the current environment increased ownership might be quite a big bite for a company the size of CDX to digest without further funding. Maybe the terms will be modified - timeline extended to allow them to focus on wearables?

Bearing in mind, despite some delays due to CV19, "We remain on track to launch in 2021 the world’s only consumer and clinical grade vital signs monitoring device that provides the highest predictive indication of hypertension and other vascular diseases."

Interesting to see how this plays out.